AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.26 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.